#United States #San Francisco #Gentuity LLC #HF-OCT Imaging #PCI Guidance

Gentuity Showcases Advanced Technology at TCT 2025

SUDBURY, Mass., October 23, 2025 — Gentuity LLC, a leading company in medical technology based in Massachusetts, is poised to make a significant impact at the upcoming Transcatheter Cardiovascular Therapeutics (TCT) Conference, scheduled for October 25-28 in San Francisco, California. With a commitment to refining intravascular imaging solutions, Gentuity aims to enhance the standards of patient care through innovative technologies that ensure precise planning and treatment for percutaneous coronary interventions (PCI).

Key Activities at TCT 2025

Gentuity will prominently feature its High-Frequency Optical Coherence Tomography (HF-OCT) Imaging System and the Vis-Rx® PRIME Micro-Imaging Catheter at booth #2041 of the conference. Attendees are invited to participate in hands-on demonstrations to see firsthand how these cutting-edge technologies provide enhanced imaging capabilities and actionable insights for pre- and post-intervention decisions.

Desmond Adler, President of Gentuity, stated: “Our continuous collaborations are focused on making our solutions more accessible while accelerating the introduction of unique capabilities. We believe these innovations will transform the planning, execution, and evaluation of PCI procedures.” At the conference, Gentuity strives to illustrate how the HF-OCT technology empowers clinicians, fostering confidence in treatment and paving the way for a comprehensive imaging strategy throughout the entire treatment pathway.

Symposium and Expert Presentations

In addition to having a strong exhibition presence, Gentuity will host an educational symposium titled “Integration of HF-OCT for Comprehensive PCI Guidance” on Monday, October 27, from 7:45 a.m. to 8:45 a.m. This symposium is moderated by Dr. Morton J. Kern and features a lineup of esteemed speakers who are experts in intravascular imaging. Key presentations include:

• - “How I Incorporated HF-OCT into my Practice” by Dr. Andreas Kalogeropoulos
• - “Small Vessel Imaging for DCB Planning” by Dr. Evan Shlofmitz
• - “Integration of Emerging PCI Planning Tools” by Dr. Hiram Bezerra

Healthcare professionals attending TCT 2025 can add this session to their calendars to explore the evolving role of HF-OCT in PCI guidance further.

Beyond the Exhibit Booth

On top of the symposium and exhibit activities, Gentuity’s HF-OCT technology will be highlighted in multiple abstract presentations. On October 26, notable topics will include:

• - “Feasibility and Safety of Lactated Ringer's Solution as a Flushing Agent for a Novel, Fast-Pullback, High-Frequency OCT Imaging” presented by Dr. Satoshi Koto
• - “Combined High-Frequency Optical Coherence Tomography and Coronary Microvascular Dysfunction Evaluation for Cardiac Allograft Vasculopathy” presented by Dr. Vivek Mehta

The TCT conference serves as the premier educational gathering for interventional cardiovascular medicine, attracting thousands of healthcare professionals globally. For over 36 years, it remains an essential forum for sharing the latest advancements in therapies and clinical research while fostering connections among specialists in the fields of vascular and interventional medicine.

Learn More About Gentuity

For further details regarding Gentuity’s groundbreaking medical technologies and products, visit www.gentuity.com or reach out via email at [email protected].

Forward-Looking Statements: This release contains forward-looking statements that involve risks and uncertainties, including various factors that could impact outcomes discussed herein. Gentuity does not intend to update or revise any forward-looking statements unless required by applicable law or regulation.

Media Contact:
Gentuity LLC
Email: [email protected]
Phone: +1 888-967-7628